IP
AGN

Isthmus Partners’s Allergan plc AGN Stock Holding History

Isthmus Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-170
Closed -$39K – 307
2016
Q3 		$39K Hold
170
– – 0.01% 183
2016
Q2 		$39K Hold
170
– – 0.01% 180
2016
Q1 		$46K Hold
170
– – 0.02% 174
2015
Q4 		$53K Hold
170
– – 0.02% 175
2015
Q3 		$46K Sell
170
-47
-22% -$14.4K 0.02% 181
2015
Q2 		$66K Buy
217
+47
+28% +$14K 0.02% 171
2015
Q1 		$51K Buy
+170
New +$48.5K 0.02% 177

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Isthmus Partners's AGN Position: Q4 2016 in Review

Isthmus Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 170 shares — an estimated $39K sold.

Isthmus Partners first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $66K in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Isthmus Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Isthmus Partners sold 170 Allergan plc shares in Q4 2016, an estimated $39K.
  • Isthmus Partners first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Isthmus Partners's Allergan plc position peaked at $66K in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Isthmus Partners's 13F filing for Q4 2016, filed 6 Feb 2017.